Nishadil
Signup Signin
Delhi | 25°C (windy)
CRISPR Therapeutics: Beyond the Hype, A Foundational Investment in Gene Editing's Future

CRISPR Therapeutics: Beyond the Hype, A Foundational Investment in Gene Editing's Future
A Bold Bet on the Future: Regeneron's $150M Investment in Gene Writing

A Bold Bet on the Future: Regeneron's $150M Investment in Gene Writing
Ginkgo Bioworks: A Deep Dive into Biology's Big Bet – Where Science Soars, But Revenue Stumbles

Ginkgo Bioworks: A Deep Dive into Biology's Big Bet – Where Science Soars, But Revenue Stumbles
The Healing Frontier: Yzi Labs Dives Headfirst into Regenerative Medicine's Bold Promise

The Healing Frontier: Yzi Labs Dives Headfirst into Regenerative Medicine's Bold Promise
Two Biotech Stories, One Volatile Market: A Deep Dive into Gossamer and Precision

Two Biotech Stories, One Volatile Market: A Deep Dive into Gossamer and Precision
Carisma Therapeutics Shares Soar Over 130% on Groundbreaking Moderna Collaboration for In Vivo CAR-M Therapies

Carisma Therapeutics Shares Soar Over 130% on Groundbreaking Moderna Collaboration for In Vivo CAR-M Therapies
Load more..